Increasing routine HIV and Hepatitis C screening is essential to slowing and ultimately ending these epidemics in the United States. One in eight HIV-positive Americans do not know they are infected, 45% of those diagnosed with HIV remain out of care, and it is estimated that 50% of people infected with HCV remain undiagnosed. Routine screening integrates HIV and HCV testing into regular care in clinics, hospitals, and other health care settings to address undiagnosed infection and engage individuals in treatment.

City Partnerships

Established in 2010, Gilead’s FOCUS program (Frontlines of Communities in the United States) partners with healthcare providers, government agencies, and community organizations to change the way healthcare institutions approach HIV and HCV testing, and develop replicable model programs that embody best practices in screening and linkage to care.

FOCUS aims to:

  • Make routine screening a standard of medical care.
  • Reduce the number of undiagnosed individuals, decrease the number of those who are diagnosed late, and ensure strong linkage to care and treatment.
  • Expand stakeholder dialogue on increasing diagnosis and access to care.
  • Change public perceptions that may discourage testing.

FOCUS works in 17 cities across the United States that are heavily impacted by HIV and HCV, including Atlanta, Baltimore, Baton Rouge, Chicago, Dallas, Detroit, Houston, Jackson, Jersey City, Los Angeles, Miami, New Orleans, New York, Newark, Oakland, Philadelphia, and Washington, D.C.

Progress to Date

FOCUS’ 200 partners have integrated routine HIV screening into a range of healthcare settings, conducting nearly 2 million tests and identifying more than 14,000 positives. In 2014, 60 partner organizations across all FOCUS cities began incorporating HCV screening and have conducted more than 160,000 tests.

Examples include:

  • Atlanta – Grady Hospital: One of the largest public hospitals in the southeastern United States, Grady Hospital provides services to more than 160,000 patients a year. Through its FOCUS partnership, the hospital has implemented routine HIV screening in its emergency department (ED) and primary care center, testing three times the number of patients in the first year of implementation than in the previous three years combined. In 24 months, Grady tested 44,000 patients and identified 350 new HIV diagnoses.
  • New York City – Urban Health Plan (UHP): This network of community health centers in the South Bronx serves more than 48,000 patients each year. With support from FOCUS, UHP integrated HIV testing and now offers routine screening system-wide. Between 2011 and 2013, UHP tested more than 32,500 patients, a five-fold increase over the preceding three-year period. In 2013, UHP initiated a multi-disciplinary learning collaborative aimed at scaling up and sharing best practices in routine HIV screening across five health centers in New York City.
  • Philadelphia – Do One Thing: Led by researchers at Brown University and Drexel University College of Medicine, Do One Thing is an HIV and HCV testing campaign in a neighborhood in southwest Philadelphia that is heavily affected by both diseases. The campaign offers testing block by block and works with a local federally-qualified health center to implement routine HIV screening.

For More Information

Download a detailed overview of Gilead’s FOCUS Program (PDF).

At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world.